Profile image
Story Views

Last Hour:
Last 24 Hours:

Worldwide Cancer Immunotherapies Market 2016 Trend, Analysis and Overview

Tuesday, November 29, 2016 1:20
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market. 

Publisher’s analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.

For more information about this report:          

Covered in this report 
The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography: 
- Americas

Publisher’s report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Merck
- Takeda Pharmaceuticals 


Request Sample Copy at          


Other prominent vendors 
- AbbVie
- ADC Therapeutics
- Agensys
- Astellas
- AstraZeneca
- Bayer
- Biogen
- Biotech Pharmaceutical
- Boehringer-Ingelheim
- Celgene
- Celldex Therapeutics
- Chugai Pharmaceutical
- CTI Biopharma
- Daiichi Sankyo
- Eli Lilly
- Fortress Biotech
- Genmab
- Immunomedics
- Intas Pharmaceuticals
- Janssen Biotech
- Kyowa Hakko Kirin
- MedImmune
- Morphotek
- Neovii Biotech
- Novartis
- OncoMed Pharmaceuticals
- Pfizer
- Sanofi
- Seattle Genetics
- Spectrum Pharmaceuticals
- TG Therapeutics
- XBiotech

Market driver 
- Increase in demand for cancer monoclonal antibodies
- For a full, detailed list, view our report 

Market challenge 
- Patent expiry of top-selling drugs
- For a full, detailed list, view our report 

Market trend 
- Emergence of targeted and combination therapies
- For a full, detailed list, view our report 

Key questions answered in this report 
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Inquire for Report at           

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.